Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced two additions to its North America regional executive team: Chris Van Dyk, Vice President of U.S. Sales, and ...

Submission is supported by 24-week results from the Phase 3b APEX study in adults with active psoriatic arthritis treated with TREMFYA.

Mediolanum International Funds Ltd made a hefty cut to its Johnson & Johnson stake, offloading 27.8% of its shares.

Tuesday, July 29, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc.

U.S. companies are removing their CEOs at the fastest clip in two decades, data shows, as increased scrutiny from ...

Johnson & Johnson MedTech (NYSE: JNJ) announced today that it launched its VirtuGuide AI-powered, patient-matched Lapidus ...

Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today ...

Johnson & Johnson (NYSE:JNJ) ranks among the stocks to benefit from an onshoring boom. On July 23, Erste Group raised the stock rating of Johnson & Johnson (NYSE:JNJ) from Hold to Buy. The firm ...

Johnson & Johnson (NYSE: JNJ) is one of the top low volatility healthcare stocks to buy now. On July 17, Guggenheim raised ...

Johnson & Johnson (NYSE:JNJ) has a sizable and broadly positioned operation, with strong representation in both the medical ...

Finding dividend stocks that are reliable and have the balance sheet stability and cash flow profile to continue to grow ...